Medartis Holding AG (XSWX:MED) Long-Term Debt: CHF112.8 Mil (As of Dec. 2025)


XSWX:MED Medartis Holding AG XSWX:MED
84 GF Score
Price CHF85.30
GF Value CHF106.42
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Medartis Holding AG Long-Term Debt?

Medartis Holding AG XSWX:MED +2.16% 84 Long-Term Debt is CHF112.8 Mil as of Dec. 2025. GuruFocus rates XSWX:MED with a GF Score™ of 84/100 and a GF Value™ of CHF106.42 (Modestly Undervalued). The stock has 5 warning signs investors should review.

Medartis Holding AG's Long-Term Debt for the quarter that ended in Dec. 2025 was CHF112.8 Mil.

Medartis Holding AG's quarterly Long-Term Debt stayed the same from Dec. 2024 (CHF0.0 Mil) to Jun. 2025 (CHF0.0 Mil) but then increased from Jun. 2025 (CHF0.0 Mil) to Dec. 2025 (CHF112.8 Mil).

Medartis Holding AG's annual Long-Term Debt stayed the same from Dec. 2023 (CHF0.0 Mil) to Dec. 2024 (CHF0.0 Mil) but then increased from Dec. 2024 (CHF0.0 Mil) to Dec. 2025 (CHF112.8 Mil).

Medartis Holding AG  (XSWX:MED) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Medartis Holding AG Long-Term Debt Related Terms

Medartis Holding AG Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Medartis Holding AG's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medartis Holding AG Long-Term Debt Chart

Medartis Holding AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.46 0.00 0.00 112.77

Medartis Holding AG Semi-Annual Data
Dec15 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 112.77
XSWX:MED
84GF Score
Medartis Holding AG XSWX:MED
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of CHF112.8 Mil mean?
Medartis Holding AG (XSWX:MED) has a Long-Term Debt of CHF112.8 Mil as of Dec. 2025.
Is Medartis Holding AG's Long-Term Debt too high?
Medartis Holding AG's current Long-Term Debt is CHF112.8 Mil. Overall, Medartis Holding AG has a GF Score™ of 84/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medartis Holding AG's Long-Term Debt compare to ABT and SYK?
Medartis Holding AG's Long-Term Debt of CHF112.8 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Medical Devices & Instruments company?
A good Long-Term Debt depends on the Medical Devices & Instruments industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Medartis Holding AG's current Long-Term Debt is CHF112.8 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medartis Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Medartis Holding AG (XSWX:MED) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF106.42, compared to a current price of CHF85.30 — trading 19.8% below its estimated fair value. The current Long-Term Debt is CHF112.8 Mil. Medartis Holding AG's overall GF Score™ is 84/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Medartis Holding AG (XSWX:MED), the current Long-Term Debt is CHF112.8 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medartis Holding AG (XSWX:MED) Overvalued in 2026?

Based on GuruFocus' analysis, Medartis Holding AG stock appears to be undervalued. The current stock price of CHF85.30 is trading 19.8% below its estimated GF Value™ of CHF106.42. GuruFocus considers Medartis Holding AG to be Modestly Undervalued.

Key valuation signals for XSWX:MED:

  • Long-Term Debt: CHF112.8 Mil
  • GF Value™: CHF106.42 vs. price of CHF85.30 (19.8% below fair value)
  • GF Score™: 84/100 with 5 warning signs

No single metric tells the full story. See the XSWX:MED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medartis Holding AG Business Description

Other Exchanges MEDz:UK1RU:Germany
Address Hochbergerstrasse 60E, Basel, CHE, 4057
Medartis Holding AG is a medical device company. The company's product profile is divided into APTUS products, StealthFix Products, and MODUS products. APTUS includes products for the Hand, Wrist, Elbow, Shoulder, and Foot. MODUS comprises products for the mandible. Geographically, it derives the majority of its revenue from Europe, Middle East and Africa (EMEA) and also has a presence in North America, Asia Pacific, and Latin America.
84GF Score

Get the complete analysis for XSWX:MED

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF85.30
Price
CHF106.42
GF Value